Suplac Special Precautions

Patients with hyperprolactinaemia should be investigated for the possibility of pituitary tumour before treatment with bromocriptine.
Hypotensive reactions may be disturbing in some patients during the first few days of treatment and those who drive or operate machinery should be warned of the possibility of dizziness and fainting during this period.
Treatment of women with hyperprolactinaemic amenorrhoea results in ovulation; patients not wishing to conceive should be advised to use contraceptive measures although oral contraceptives should be avoided.
Bromocriptine should also not be used postpartum or in the puerperium in women with hypertension, coronary artery disease, or symptoms or a history of serious psychiatric disorders. When used, blood pressure should be monitored carefully, especially during the first few days in postpartum women.
Patients on long-term, high dose therapy should be monitored for signs of progressive fibrotic disorders such as retroperitoneal fibrosis.